Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more
Biotechnology Pfizer-Acquired Seagen’s Adcetris Combo Therapy Extends Overall Survival Versus Placebo In Patients With Most Common Type Of Lymphoma – Pfizer (NYSE:PFE) Read more
Biotechnology MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds – Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study Read more
Biotechnology MindMed Receives FDA ‘Breakthrough Therapy’ Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials – Compass Pathways (NASDAQ:CMPS), Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows – GSK (NYSE:GSK), Pfizer (NYSE:PFE) Read more
Stockmarkets INmune Bio reports EEG improvement in Alzheimer’s therapy By biedexmarkets.com Read more
Biotechnology Novartis Reveals Promising Gene Therapy Data for Treating Spinal Muscular Atrophy in Older Children – Novartis (NYSE:NVS) Read more